Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Ezetimibe, Niacin, and Colestipol as Adjuncts to Statins in Hyperlipidemia
NCT00203476Phase 4Completed
- Sponsor
- Tuscaloosa Research and Education Advancement Corporation
- Start
- May 2005
- Primary completion
- Jan 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ezetimibe, niacin, colestipol in hyperlipidemia, hypercholesterolemia, sponsored by Tuscaloosa Research and Education Advancement Corporation. Started May 2005; status: completed.
02
Drugs
ezetimibeniacincolestipol
03
Conditions
hyperlipidemiahypercholesterolemia
Beyond the preview
Go deeper on NCT00203476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00203476.